Blood Collection Devices Market
The increasing cases of chronic diseases around the world is expected to foster healthy growth of the market, states Fortune Business Insights, in a report, titled “Blood Collection Devices Market Size, Share & Industry Analysis, By Product (Blood Collection Tubes, Needles and Syringes, Others), By Method (Manual Blood Collection, Automated Blood Collection), By End User (Hospitals & Clinics, Diagnostic and Pathology Centers, Blood Banks, Others) and Regional Forecast 2020-2027.” The growing awareness about blood tests can enable speedy expansion of the market.
The catastrophe caused by coronavirus has disrupted the supply chain of every industry around the world. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. Some industries are struggling, and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.
We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.
The report on the blood collection devices market contains:
• An insightful study of the market
• Vital market trends and drivers
• Emerging industry developments
• All-inclusive data about eminent players
• Competitive landscape
Increasing Diagnosis and Treatment of Diseases to Encourage Growth
The increasing number of diseases such as diabetes, cardiovascular diseases, and cancers can spur the market opportunities. The launch of more technologically advanced blood collection devices is expected to aid the expansion of the market. Blood donation can be efficiently conducted with the aid of technologically advanced blood collection devices. The rising availability of sophisticated blood collection devices in many healthcare processes is expected to bode well for the market. The increasing geriatric population is expected to create opportunities for the market. The growing technological advancements in blood collection devices is expected to foster the growth of the market. For instance, in June 2016, Becton, Dickinson, and Company (BD) announced the launch of a new safety blood collection set – the BD Vacutainer UltraTouch Push Button Blood Collection Set – in the UK, after achieving European CE marking. However, the lack of adequate testing in developing nations is expected to dampen the market’s growth during the forecast period.
Evolving Healthcare Infrastructure to Favor Growth in Asia Pacific
North America is expected to dominate the global market during the forecast period owing to the substantial prevalence of chronic diseases. The increasing testing numbers among the general population and technological advancements in blood collection devices is expected to proliferate in the region. According to the National Cancer Institute, in 2018, an estimated 1,735,350 new cancer cases will be diagnosed in the United States. Europe is expected to account for the largest share during the forecast period. Robust blood testing, strong awareness about chronic diseases, and advanced healthcare infrastructure are factors expected to aid expansion in Europe. Asia Pacific is expected to rise excellently during the forecast period owing to the advancement in healthcare infrastructure. The growing awareness regarding serious diseases is expected to create lucrative opportunities for the market in Asia Pacific. Latin America and the Middle East & Africa are expected to account for the largest share during the forecast period due to improved healthcare infrastructure coupled with increasing blood testing volume in these regions.
For any queries before buying, please visit: https://www.fortunebusinessinsights.com/enquiry/queries/blood-collection-devices-market-103500
July 2020: Magnolia Medical announced the launch of Steripath Gen2 with an integrated syringe, addressed to the patients with difficult intravenous access (DIVA) or the ‘hard stick’ patient population
January 2018: DBS System introduced the HemaXis DB micro blood collection device with FDA listing in the United States
The Report Lists the key Companies in the Blood Collection Devices Market:
• Terumo Medical Corporation
• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Nipro Medical Corporation
• FL MEDICAL s.r.l.
• GmbHer Bio-One International GmbH
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US:+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]